Phone: (919) 966-8035
B.A., Transylvania University
Ph.D., University of Kentucky College of Medicine
M.D., University of Kentucky College of Medicine
Residency in Psychiatry, University of Virginia Health System
Dr. Rau is the Clinical Director of the North Carolina Psychiatric Research Center (NCPRC: formerly the Clinical Research Unit). The NCPRC is an outpatient division of Central Regional Hospital and is housed in the Scott Building on the Dix Campus in Raleigh, NC. Dr. Rau and his colleagues at the NCPRC conduct a variety of clinical trials focused on finding new and/or improved treatments for psychotic disorders such as schizophrenia and schizoaffective disorder. The NCPRC also provides expert psychiatric consultative services, medication management (including a developing clozapine clinic), case management and psychotherapy services via a multi-disciplinary clinical team. In addition, Dr. Rau has an interest in graduate medical education and has taken on the role of the Director of Medical Education for the Center for Excellence in Community Mental Health (CECMH). Through this role, he will work with CECMH colleagues to develop and maintain a curriculum to train psychiatry residents to provide excellent care to persons who suffer severe and persistent mental illness.
Dr. Rau’s current research interest centers on improving the clinical care of persons who suffer severe and persistent mental illness. One current project is the development of a data core for the CECMH. The core will consist of a clinical database and steering workgroup that will generate an infrastructure for quality management projects and serve as a resource for CECMH researchers. A primary goal for this new infrastructure will be to encourage the advancement of mental health services research at the CECMH.
- Pedersen CA, Gibson CM, Rau SW, Salimi KS, Smedley KL, Casey RL, Leserman J, Jarskog LF, Penn DL. 2011. Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia. Schizophrenia Research. 132(1): 50-3.
- Suzuki S, Gerhold LM, Bottner M, Rau SW , DelaCruz C, Yang E, Zhu H, Yu J, Cashion AB, K, Kindy MS, Merchenthaler I, Gage FH, and Wise PM. 2007 . Estradiol Enhances Neurogenesis Following Ischemic Stroke Through Estrogen Receptors alpha and beta. The Journal of Comparative Neurology. 500: 1064-1075.
- Dubal DB*, Rau SW *, Shughrue PJ, Zhu H, Yu J, Cashion AB, Suzuki S, Gerhold L, Bottner MB, Dubal SB, Merchanthaler I, Kindy MS, and Wise PM. 2006 . Differential Modulation of Estrogen Receptors (ERs) in Ischemic Brain Injury: A Role for ER alpha in Estradiol-Mediated Protection Against Delayed Cell Death. Endocrinology . 147(6): 3076-3084. (*These authors contributed equally to this work)
- Rau SW, Dubal DB, Bottner M, Gerhold LM, Wise PM. 2003. Estradiol attenuates markers of programmed cell death after focal cerebral ischemia. Journal of Neuroscience. 23(36): 11420-11426.